Steve Perry
Impact in
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
- Toxicology top 5%
Papers in
-
- Receptor Mechanisms and Signaling 3
- Genomics, phytochemicals, and oxidative stress 3
- Bioactive natural compounds 2
-
- Inflammatory mediators and NSAID effects 4
- Fungal Biology and Applications 2
- Co-authors
- Theodore R. Holman (15 shared papers)Netra Joshi (6 shared papers)Michael Holinstat (7 shared papers)Anton Simeonov (7 shared papers)Ajit Jadhav (7 shared papers)David J. Maloney (6 shared papers)Lena Schultz (5 shared papers)Domenico Praticò (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (3 papers)Biochemistry (3 papers)Journal of Lipid Research (1 paper)Bioorganic & Medicinal Chemistry (1 paper)Journal of Natural Products (1 paper)
- Partner nations
- United StatesChileCanada
In The Last Decade
Steve Perry
18 papers receiving 731 citations
Peers
Comparison fields: 5 of 78
- Biochemistry 123
- Toxicology 43
- Cancer Research 120
- Pharmacology 124
- Pulmonary and Respiratory Medicine 173
Countries citing papers authored by Steve Perry
This map shows the geographic impact of Steve Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Perry more than expected).
Fields of papers citing papers by Steve Perry
This network shows the impact of papers produced by Steve Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Perry. The network helps show where Steve Perry may publish in the future.
Co-authors
The 25 scholars most cited alongside Steve Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 238 | |
| 2 | 2014 | 86 | |
| 3 | 2014 | 65 | |
| 4 | 2011 | 55 | |
| 5 | 2015 | 42 | |
| 6 | 2013 | 40 | |
| 7 | 2020 | 38 | |
| 8 | 2013 | 32 | |
| 9 | 2020 | 28 | |
| 10 | 2021 | 19 | |
| 11 | 2013 | 18 | |
| 12 | Discovery of ML355, a Potent and Selective Inhibitor of Human 12-Lipoxygenase | 2014 | 17 |
| 13 | 2020 | 14 | |
| 14 | 2013 | 12 | |
| 15 | Discovery of ML351, a Potent and Selective Inhibitor of Human 15-Lipoxygenase-1 | 2014 | 12 |
| 16 | 2014 | 10 | |
| 17 | 2023 | 7 | |
| 18 | 2022 | 4 |
About Steve Perry
Steve Perry is a scholar working on Molecular Biology, Pharmacology, Biochemistry, Toxicology and Nutrition and Dietetics, having authored 18 papers that have together received 737 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (6 papers), Fatty Acid Research and Health (5 papers), Bioactive Compounds and Antitumor Agents (5 papers), Inflammatory mediators and NSAID effects (4 papers), Receptor Mechanisms and Signaling (3 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Bioactive natural compounds (2 papers) and Fungal Biology and Applications (2 papers). The work is most often cited by research in Biochemistry (123 citations), Toxicology (43 citations), Cancer Research (120 citations), Pharmacology (124 citations) and Pulmonary and Respiratory Medicine (173 citations). Steve Perry has collaborated with scholars based in United States, Chile and Canada. Frequent co-authors include Theodore R. Holman, Netra Joshi, Michael Holinstat, Anton Simeonov, Ajit Jadhav, David J. Maloney, Lena Schultz, Domenico Praticò, Victor Darley‐Usmar and Megan W. Bourassa. Their work appears in journals such as Journal of Medicinal Chemistry, Biochemistry, Journal of Lipid Research, Bioorganic & Medicinal Chemistry and Journal of Natural Products.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.